(Reuters) -Medtech firm Staar Surgical’s biggest investor, Broadwood Partners, is planning to call a shareholder meeting to remove several directors, it said on Wednesday, amid tensions over a proposed takeover by Swiss eyecare firm Alcon.

Investment firm Broadwood has 27.5% stake and has actively opposed Alcon’s acquisition, saying the offer did not reflect Staar’s recent financial improvements and that the board has failed to fully assess alternative options.

“It is clear to us that the board no longer has the confidence of shareholders, and that new directors are needed to properly steward the Company and restore shareholder trust,” Neal Bradsher, Broadwood founder and president, said.

The special shareholder meeting to remove certain directors is scheduled for Thursday when investor

See Full Page